The American Journal of Pathology
Volume 180, Issue 3 , Pages 1028-1039, March 2012

Plasmodium falciparum Histones Induce Endothelial Proinflammatory Response and Barrier Dysfunction

  • Mark R. Gillrie

      Affiliations

    • Department of Microbiology Immunology & Infectious Diseases, University of Calgary, Alberta, Canada
  • ,
  • Kristine Lee

      Affiliations

    • Department of Microbiology Immunology & Infectious Diseases, University of Calgary, Alberta, Canada
  • ,
  • D. Channe Gowda

      Affiliations

    • Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania
  • ,
  • Shevaun P. Davis

      Affiliations

    • Department of Microbiology Immunology & Infectious Diseases, University of Calgary, Alberta, Canada
  • ,
  • Marc Monestier

      Affiliations

    • Temple Autoimmunity Center, Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania
  • ,
  • Liwang Cui

      Affiliations

    • Department of Entomology, Pennsylvania State University, University Park, Pennsylvania
  • ,
  • Tran Tinh Hien

      Affiliations

    • Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
  • ,
  • Nicholas P.J. Day

      Affiliations

    • Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
  • ,
  • May Ho

      Affiliations

    • Department of Microbiology Immunology & Infectious Diseases, University of Calgary, Alberta, Canada
    • Corresponding Author InformationAddress reprint requests to May Ho, M.D., Department of Microbiology and Infectious Diseases, 3330 Hospital Dr. NW, Calgary, AB, Canada T2N 4N1

Accepted 4 November 2011. published online 18 January 2012.

Plasmodium falciparum is a protozoan parasite of human erythrocytes that causes the most severe form of malaria. Severe P. falciparum infection is associated with endothelial activation and permeability, which are important determinants of the outcome of the infection. How endothelial cells become activated is not fully understood, particularly with regard to the effects of parasite subcomponents. We demonstrated that P. falciparum histones extracted from merozoites (HeH) directly stimulated the production of IL-8 and other inflammatory mediators by primary human dermal microvascular endothelial cells through a signaling pathway that involves Src family kinases and p38 MAPK. The stimulatory effect of HeH and recombinant P. falciparum H3 (PfH3) was abrogated by histone-specific antibodies. The release of nuclear contents on rupture of infected erythrocytes was captured by live cell imaging and confirmed by detecting nucleosomes in the supernatants of parasite cultures. HeH and recombinant parasite histones also induced endothelial permeability through a charge-dependent mechanism that resulted in disruption of junctional protein expression and cell death. Recombinant human activated protein C cleaved HeH and PfH3 and abrogated their proinflammatory effects. Circulating nucleosomes of both human and parasite origin were detected in the plasma of patients with falciparum malaria and correlated positively with disease severity. These results support a pathogenic role for both host- and pathogen-derived histones in P. falciparum-caused malaria.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a Canadian Institutes of Health Research (CIHR) grant MT14104 (M.H.). M.H. is a Scientist of Alberta Innovates-Research Solution, Canada. M.R.G. is supported by an M.D./Ph.D. scholarship from CIHR.

 Supplemental material for this article can be found at http://ajp.amjpathol.org or at doi: 10.1016/j.ajpath.2011.11.037.

PII: S0002-9440(11)01109-6

doi:10.1016/j.ajpath.2011.11.037

The American Journal of Pathology
Volume 180, Issue 3 , Pages 1028-1039, March 2012